Viewing nowCombinationAtorvastatin Calcium/Ezetimibe Tablets 10/40 mg
Atorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Prime Pharma Co., Ltd.

MFDS item code 202100177 · Approved 2021.01.08
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This drug is used as an adjunct to diet to lower total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL cholesterol. It is primarily used in conjunction with a diet that includes restrictions on saturated fats and cholesterol intake and is applied when diet alone is insufficient. It is administered for lipid control in patients at high risk of cardiovascular disease, but other risk factors must be considered. Prior to administration, it is important to check for other secondary causes of dyslipidemia and treat if necessary, and it is essential to closely monitor the condition through lipid tests. This drug can only be used for certain types of dyslipidemia, and its superior efficacy over atorvastatin has not been established. Therefore, it is recommended to follow the guidance of professionals for safe and effective treatment.
Administer this medicine once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The recommended initial dose is 10/10 mg or 10/20 mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly.
This drug has been reported to cause a rare side effect called rhabdomyolysis, which can lead to serious muscle damage. Patients with severe infections, hypotension, major surgeries or trauma, metabolic and electrolyte disorders should temporarily suspend or discontinue the use of this drug. This drug should not be administered to certain patients. For example, those who are allergic to its components, have severe liver dysfunction, muscle diseases, are pregnant or nursing mothers, or are taking certain antiviral drugs. Additionally, patients with genetic issues such as lactose intolerance should not take this drug. Patients with a history of liver disease or alcoholics, patients with decreased kidney function, hypothyroidism, the elderly, and those at high risk of muscle damage should use this drug cautiously. Caution is also necessary when taking fibrate class drugs concurrently. During the use of this drug, side effects such as abnormal liver function, muscle pain, fatigue, headache, dizziness, dyspepsia, hypertension, and diabetes may occur. In severe cases, hepatitis, muscle rupture, and serious skin reactions can occur, so immediate consultation with a doctor is advised if symptoms appear. If muscle-related abnormal symptoms occur, blood tests should be done to check for the extent of muscle damage, and in severe cases, medication should be discontinued. Rapid notification to medical personnel is essential if accompanied by muscle pain, muscle weakness, malaise, or fever. Liver function tests should be performed before starting treatment and regularly during treatment, and if liver values increase significantly, dosage may be reduced or discontinued. Women who are pregnant or potentially pregnant should not take this drug, and women of childbearing age should use appropriate contraception while taking this drug. It is also safer not to use this drug during breastfeeding. Safety and efficacy have not been established in children, so it is not recommended for their use. Caution is needed in the elderly due to the higher risk of muscle abnormalities, but no separate dosage adjustment is necessary. There are many interactions with other drugs, so the dosage adjustment or use of this drug should be decided based on the concomitant medications. Special caution is required when co-administered with drugs that affect liver metabolism or increase the risk of muscle damage. In the case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle damage should be monitored.
Acute renal failure due to myoglobinuria, rhabdomyolysis, sensory impairment, sensory abnormalities, hypertension, increased ALT, increased GGT, nasopharyngitis, cough, itching, dizziness, diabetes, lethargy, fatigue, chest pain, peripheral edema, fatigue, fever, hyperglycemia, hypoglycemia, weight gain, anorexia, constipation, abdominal distension, indigestion, nausea, diarrhea, abdominal pain, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleeds, insomnia, nightmares, headache, sensory loss, taste disorders, memory loss, peripheral neuropathy, myalgia, arthralgia, limb pain, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, abnormal liver function tests, increased serum creatine kinase, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, hepatitis, pancreatitis, cholestasis, cholestatic jaundice, abnormal liver function tests, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, postprandial urgency, bronchitis, rhinitis, pneumonia, dyspnea, asthma, bradycardia, hypotension, anemia, hernia, hyperkalemia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, increased serum creatinine, elevated blood pressure, increased serum urea, elevated CPK, abnormal liver function, fatigue, chest discomfort, edema, generalized edema, diabetic neuropathy, tremors, epigastric pain, gastritis, dry mouth, discomfort in the epigastric region, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, tachycardia, cerebral infarction, palpitations, anaphylaxis, urticaria, rash, vascular edema, arthralgia, myalgia, myopathy, rhabdomyolysis, hepatitis, thrombocytopenia, nausea, cholelithiasis, drug-induced liver injury, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia and systemic symptom-associated drug reactions, erythema multiforme, sleep disorders, memory loss, sexual dysfunction, cognitive impairment, severe myasthenia gravis, ocular myasthenia gravis
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture, and the temperature should be maintained between 1 and 30 degrees Celsius. Storing it this way can maintain the drug's effectiveness for a long time.
White oval film-coated tablet
For domestic use - 30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Prime Pharma Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.